1-3 of 3
Jeannie Callum, MD, FRCPC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study

Francesco Passamonti, MD, Francesca Palandri, MD PhD, Guray Saydam, MD, Miklos Egyed, MD PhD, Jeannie Callum, MD FRCPC, Timothy Devos, MD, Serdar Sivgin, MD, Paola Guglielmelli, MD, Alessandro M. Vannucchi, MD, Evren Zor, MD, Geralyn Gilotti, MSc, Yifan Zhang, PhD, Martin Griesshammer, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-139281
Published: 2020
Journal Articles

Utilization and Costs of Red Blood Cell Transfusions Pre- and Post-Azacitidine in Higher-Risk Myelodysplastic Syndromes

Eric Tseng, MD, Soojin Seung, B.Sc, Nicole Mittmann, PhD, Jeannie Callum, MD, FRCPC, Richard A. Wells, MD, DPhil, Tony Kim, M.A., Rena Buckstein, MD
Journal: Blood
Blood (2012) 120 (21): 4261.
https://doi.org/10.1182/blood.V120.21.4261.4261
Published: 2012
Journal Articles

Characteristics and Outcomes of Patients Receiving Massive Transfusions at a Tertiary Care Centre

Sita Bhella, MD, Sandro Rizoli, MD, PhD, FRCSC, FASC, Jeannie Callum, MD, FRCPC
Journal: Blood
Blood (2010) 116 (21): 4412.
https://doi.org/10.1182/blood.V116.21.4412.4412
Published: 2010